Skip to main content

DEPARTMENT OF ENT, HEAD AND NECK SURGERY

 

INTRODUCTION

 

Our department has the capability to carry out successful Phase III clinical trials. We are primarily equipped for examinations in rhinology, audiology, otology, and head and neck oncology. Our units, (allergology, and objective and subjective audiology), our large number of patients from the entire country, our excellent health specialists and our equipment park ensure that the clinical trials will be implemented successfully

 

Number of clinical trial investigators with Good Clinical Practice (GCP) certificate : 2 
Number of clinical trial doctors with Good Clinical Practice (GCP) certificate: 7
Number of specialist doctors with Clinical Pharmacology certificate: 0
 

 

EQUIPMENT FOR CLINICAL TRIALS

  • objective vestibular examinations:
  • otometrics ICS impulse video oculograph for objective recording of spontaneous nystagmus, positional nystagmus, oculomotor tests and head-impulse tests
  • videonystagmograph for objective recording of spontaneous nystagmus, oculomotor tests, caloric stimulation
  • cVEMP
  • objective audiological tests (BERA, ASSR, MLR, MFT, STR, OAE)
  • stroboscope
  • fiberscope
  • high resolution operation microscope
  • 0, 30, 70 degree nose endoscope, with video recording
  • 0, 30, 45 degree ear endoscope
  • navigation system for sinus and skull base surgeries
  • neuromonitor

 

 

REFERENCE CLINICAL TRIALS

 

  

 

Protokoll száma

Vizsgálat neve

Vizsgálatvezető neve

1

D5242C00001
 

Multicentre, randomized, double-blind, parallel
placebo-controlled, Phase 3 clinical trial to evaluate tezepelumab and its safety in patients with rhinosinusitis with nasal polyposis (WAYPOINT).

Dr. István Szanyi

2

LPS16747 / EVEREST

A randomised, double-blind, head-to-head comparison of dumilumab and omalizumab in patients with severe chronic rhinosinusitis with nasal polyps (CRSWNP) and asthma comorbidities

Dr. László Lujber

3

 

 

 

 

EFC16723

Randomised, double-blind, placebo-controlled, 2-part trial to evaluate the efficacy and safety of dupilumab in uncontrolled patients with chronic rhinosinusitis without nasal polyposis (CRSsNP).
 

Dr. László Lujber

 

   

 

PRINCIPAL INVESTIGATIONS

 

 

 

 

 

 

Dr. habil István Szanyi PhD

Dr. Szanyi István

 

POSITION

Director, University Associate Professor

QUALIFICATIONS

Otorhinolaryngology, Audiology, Phoniatrics

LICENCE VIZSGA

foniátria

SCIENTIFIC INTEREST

molecular examination of head and neck tumors, thyroid surgery, functional endoscopic sinus surgery, pathophysiology of chronic rhinosinusitis, use of KTP-532 laser in sinus and middle ear surgery, modern implantation methods in hearing improvement, pituitary surgery, stapes surgery, endoscopic ear surgery, head and neck oncology

REFERENCE TESTS

D5242C00001 Multicentre, randomized, double-blind, parallel placebo-controlled, Phase 3 clinical trial to evaluate tezepelumab and its safety in patients with rhinosinusitis with nasal polyposis (WAYPOINT).

AVAILABLE FOR PERFORMING CLINICAL TRIALS

Phase 2-4

 

 

  

 

 

 

Dr. habil László Lujber PhD

POSITION

University Associate Professor

QUALIFICATIONS

Otorhinolaryngology, Audiology

REFERENCE CLINICAL TRIALS

LPS16747 / EVEREST A randomised, double-blind, head-to-head comparison of dumilumab and omalizumab in patients with severe chronic rhinosinusitis with nasal polyps (CRSWNP) and asthma comorbidities.

EFC16723A Randomised, double-blind, placebo-controlled, 2-part trial to evaluate the efficacy and safety of dupilumab in uncontrolled patients with chronic rhinosinusitis without nasal polyposis (CRSsNP).
 
AVAILABLE FOR PERFORMING CLINICAL TRIALS

Phase 2-4

 

 

STUDY TEAM

 

 

Study Coordinators

The department is currently training 2 study coordinators.
 

 

Name

Phone

Email

Nikoletta Egri

+36 72 507 300

egri.nikoletta@pte.hu

Gabriella Schober

+36 72 507 300

schober.gabriella@pte.hu

 

Study Nurses


Two study nurses are working at our department currently.

Number of study nurses with master degree (MSc): 0
Number of study nurses with bachelor degree (BSc): 0
Number of study nurses with further education degree: 2
 

Name

Phone

Email

Csilla Gondos

+36 72 507 378

gondos.csilla73@freemail.hu

Andrea Hermann Horváthné

+36 72 507 300

hermann.andrea@pte.hu

 

 

 

 

Created: 02/08/2019.
Last updated: 09.04.2019.